SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-005959
Filing Date
2021-02-24
Accepted
2021-02-24 08:45:24
Documents
14
Period of Report
2021-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10020770_8k.htm   iXBRL 8-K 25918
2 EXHIBIT 99.1 brhc10020770_ex99-1.htm EX-99.1 329958
6 image0.jpg GRAPHIC 11774
  Complete submission text file 0001140361-21-005959.txt   533711

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20210224.xsd EX-101.SCH 4204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20210224_lab.xml EX-101.LAB 22718
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20210224_pre.xml EX-101.PRE 16222
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10020770_8k_htm.xml XML 4078
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 21668841
SIC: 2834 Pharmaceutical Preparations